Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronomodulated 5-FU +/- Cisplatin in Pancreatic Cancer
NCT00003029Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 1997
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of cisplatin, fluorouracil in pancreatic cancer (PC), sponsored by European Organisation for Research and Treatment of Cancer. Started May 1997; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00003029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003029.